TD Asset Management Inc Invests $200,000 in Balchem Co. (NASDAQ:BCPC)

TD Asset Management Inc bought a new stake in shares of Balchem Co. (NASDAQ:BCPC) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,300 shares of the basic materials company’s stock, valued at approximately $200,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Private Advisor Group LLC purchased a new position in Balchem in the fourth quarter worth about $209,000. Principal Securities Inc. purchased a new position in shares of Balchem in the 4th quarter worth approximately $28,000. Dimensional Fund Advisors LP increased its position in shares of Balchem by 1.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 687,485 shares of the basic materials company’s stock valued at $102,265,000 after purchasing an additional 11,629 shares during the last quarter. Vanguard Personalized Indexing Management LLC raised its holdings in Balchem by 16.2% during the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 2,826 shares of the basic materials company’s stock valued at $420,000 after buying an additional 394 shares during the period. Finally, Brown Advisory Inc. purchased a new stake in Balchem during the 4th quarter valued at $240,000. 87.91% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. HC Wainwright boosted their price objective on shares of Balchem from $170.00 to $185.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. StockNews.com lowered shares of Balchem from a “buy” rating to a “hold” rating in a research report on Monday, July 29th.

Balchem Price Performance

Shares of BCPC stock opened at $172.41 on Tuesday. The stock has a 50 day moving average price of $170.34 and a 200 day moving average price of $158.66. The firm has a market capitalization of $5.59 billion, a P/E ratio of 48.70, a P/E/G ratio of 5.18 and a beta of 0.65. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.79 and a current ratio of 2.83. Balchem Co. has a 52-week low of $110.74 and a 52-week high of $186.03.

Balchem (NASDAQ:BCPC) last released its earnings results on Friday, July 26th. The basic materials company reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.03. The business had revenue of $234.08 million during the quarter, compared to the consensus estimate of $241.26 million. Balchem had a return on equity of 10.94% and a net margin of 12.52%. As a group, sell-side analysts predict that Balchem Co. will post 3.96 earnings per share for the current year.

Insider Buying and Selling at Balchem

In other news, SVP Gunsteren Job Leonard Van sold 7,750 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $180.05, for a total transaction of $1,395,387.50. Following the transaction, the senior vice president now directly owns 8,540 shares of the company’s stock, valued at $1,537,627. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.25% of the stock is owned by corporate insiders.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.